Search
for
Sort by
Research 541–570 of 851
- Myxedema Coma and Acute Hepatopathy in a Dog with Severe Atherosclerosis
- A Review on the Form and Complexity of Human–Robot Interaction in the Evolution of Autonomous Surgery
- Peptide-Based Approaches for Pain Relief and Healing in Wounds
- Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata
- High-Dose Baricitinib for Severe Alopecia Areata with Suboptimal Response to Conventional Therapy: A Real-World Assessment
- Serum biotin and zinc in male androgenetic alopecia
- Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome
- Alopecia androgénica en una paciente con lupus eritematoso sistémico
- Histopathological and Biochemical Evaluation of Diffuse Hair Loss in Women: A Cross-sectional Study
- Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
- The importance of the vitamin d and its effects on the human organism
- Congress abstracts SPEDM
- Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Natural hair patterns
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Platelet-derived chemokines promote skeletal muscle regeneration by guiding neutrophil recruitment to injured muscles
- Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia
- Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia-Pacific and Latin America
- Aesthetic Management of External Skin Paddles Following Microvascular Reconstruction of the Head and Neck